Breast cancer cells can directly stimulate osteoclastogenesis by secreting factors such as receptor activator of nuclear factor kappa-Β ligand (RANKL), IL-1, IL-6, and tumor necrosis factor-alpha (TNF-α) (Le Pape et al., 2016). This evidence concerns the gene IL6 and breast carcinoma.